Cleveland BioLabs Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Cleveland BioLabs are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Cleveland BioLabs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong essential indicators, Cleveland BioLabs is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Quick Ratio | 28.22 | |
| Fifty Two Week Low | 2.7000 | |
| Fifty Two Week High | 5.6400 |
Cleveland |
Cleveland BioLabs Relative Risk vs. Return Landscape
If you would invest (100.00) in Cleveland BioLabs on October 11, 2025 and sell it today you would earn a total of 100.00 from holding Cleveland BioLabs or generate -100.0% return on investment over 90 days. Cleveland BioLabs is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Cleveland, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cleveland BioLabs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cleveland BioLabs' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cleveland BioLabs, and traders can use it to determine the average amount a Cleveland BioLabs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CBLI |
Based on monthly moving average Cleveland BioLabs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cleveland BioLabs by adding Cleveland BioLabs to a well-diversified portfolio.
Cleveland BioLabs Fundamentals Growth
Cleveland Stock prices reflect investors' perceptions of the future prospects and financial health of Cleveland BioLabs, and Cleveland BioLabs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cleveland Stock performance.
| Return On Equity | -31.86 | |||
| Return On Asset | -20.33 | |||
| Current Valuation | 66.46 M | |||
| Shares Outstanding | 15.47 M | |||
| Price To Earning | (4.57) X | |||
| Price To Book | 5.32 X | |||
| Price To Sales | 458.71 X | |||
| Revenue | 106.9 K | |||
| EBITDA | (2.68 M) | |||
| Cash And Equivalents | 14.62 M | |||
| Cash Per Share | 0.94 X | |||
| Debt To Equity | 0.15 % | |||
| Book Value Per Share | 0.60 X | |||
| Cash Flow From Operations | (2.31 M) | |||
| Earnings Per Share | (0.18) X | |||
| Total Asset | 20.88 M | |||
| Retained Earnings | (179.87 M) | |||
| Current Asset | 20.69 M | |||
| Current Liabilities | 5.84 M | |||
Things to note about Cleveland BioLabs performance evaluation
Checking the ongoing alerts about Cleveland BioLabs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cleveland BioLabs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cleveland BioLabs is not yet fully synchronised with the market data | |
| Cleveland BioLabs has some characteristics of a very speculative penny stock | |
| Cleveland BioLabs has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 106.9 K. Net Loss for the year was (2.35 M) with loss before overhead, payroll, taxes, and interest of (428.13 K). | |
| Cleveland BioLabs currently holds about 14.62 M in cash with (2.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.94. | |
| Roughly 50.0% of the company shares are held by company insiders |
- Analyzing Cleveland BioLabs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cleveland BioLabs' stock is overvalued or undervalued compared to its peers.
- Examining Cleveland BioLabs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cleveland BioLabs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cleveland BioLabs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cleveland BioLabs' stock. These opinions can provide insight into Cleveland BioLabs' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Cleveland Stock
If you are still planning to invest in Cleveland BioLabs check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cleveland BioLabs' history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |